Melatonin modulates the effects of gastric injury in rats: Role of prostaglandins and nitric oxide

NeuroSignals

Volumn 12, Issue 2, 2003, Pages 71-77

  Cabeza, Juan ^a   Alarcón De La Lastra, Catalina ^a   Jiménez, Dolores ^a   Martín, María José ^a   Motilva, Virginia ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

cGMP; Cyclooxygenase expression; Gastric; Ischemia reperfusion; Melatonin; Nitric oxide; Prostaglandins

Indexed keywords

CYCLIC GMP; ICOSANOID; MELATONIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; ANTIOXIDANT; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; IMMUNOLOGICAL TECHNIQUE; IN VIVO STUDY; ISCHEMIA; MALE; METABOLISM; MODULATION; NONHUMAN; RAT; REPERFUSION; STOMACH INJURY; STOMACH MUCOSA LESION; STOMACH PROTECTION; ANIMAL; REPERFUSION INJURY; STOMACH DISEASE; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; CYCLIC GMP; DINOPROSTONE; FEMALE; MALE; MELATONIN; NITRIC OXIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; REPERFUSION INJURY; STOMACH DISEASES;

EID: 0042387732     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071816     Document Type: Article

References (56)

1. Bubenik GA: Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 2001;10:350-366.
2. Konturek PC, Konturek SJ, Brzozowski T, Dembinski A, Zembala M, Mytar B, Hahn EG: Gastroprotective activity of melatonin and its precursor, L-tryptophan, against stress-induced and ischemia-induced lesions is mediated by scavenge of oxygen radicals. Scand J Gastroenterol 1997;32:433-438.
3. Kato K, Murai I, Asai S, Komuro S, Matsuno Y, Matsukawa Y, Kurosaka H, Iwasaki A, Ishikawa K, Arakawa Y: Central effect of melatonin against stress-induced gastric ulcers in rats. Neuroreport 1997;8:2305-2309.
4. Kato K, Asai S, Murai I, Nagata T, Takahashi Y, Komuro S, Iwasaki A, Ishikawa K, Arakawa Y: Melatonin's gastroprotective and antistress roles involve both central and peripheral effects. J Gastroenterol 2001;36:91-95.
5. Bandyopadhyay D, Biswas K, Bandyopadhyay U, Reiter RJ, Banerjee RK: Melatonin protects against stress-induced gastric lesions by scavenging the hydroxyl radical. J Pineal Res 2000;29:143-151.
6. Melchiorri D, Sewerynek E, Reiter RJ, Ortiz GG, Poeggeler B, Nistico G: Suppressive effect of melatonin administration on ethanol-induced gastroduodenal injury in rats in vivo. Br J Pharmacol 1997;121:264-270.
7. El-Sokkary GH, Reiter RJ, Tan TD, Kim SJ, Cabrera J: Inhibitory effect of melatonin on products of lipid peroxidation resulting from chronic ethanol administration. Alcohol 1999;34:842-850.
8. Alarcón de la Lastra, C, Motilva V, Martin MJ, Nieto A, Barranco MD, Cabeza J, Herrerias JM: Protective effect of melatonin on indomethacin-induced gastric injury in rats. J Pineal Res 1999;26:101-107.
9. Sener-Muratoglu G, Paskaloglu K, Arbak S, Hurdag C, Ayanoglu-Dulger G: Protective effect of famotidine, omeprazole and melatonin against acetylsalicylic acid-induced gastric damage in rats. Dig Dis Sci 2001;46:318-330.
10. Bandyopadhyay D, Bandyopadhyay A, Das PK, Reiter RJ: Melatonin protects against gastric ulceration and increases the efficacy of ranitidine and omeprazole in reducing gastric damage. J Pineal Res 2002;33:1-7.
11. Bandyopadhyay D, Biswas K, Bandyopadhyay U, Reiter RJ, Banerjee RK: Melatonin protects against stress-induced gastric lesions by scavenging the hydroxyl-radical. J Pineal Res 2000;29:143-151.
12. De La Lastra CA, Cabeza J, Motilva V, Martin MJ: Melatonin protects against gastric ischemia-reperfusion injury in rats. J Pineal Res 1997;23:47-52.
13. Kotler M, Rodriguez C, Sainz RM, Antolin I, Menendez-Pelaez A: Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998;24:83-89.
14. Cabeza, J, Motilva V, Martín MJ, de la Lastra C: Mechanisms involved in gastric protection of melatonin against oxidant stress by ischemia-reperfusion in rats. Life Sci 2001;68:1405-1415.
15. Kitahora T, Guth PH: Ischemia-reperfusion induced gastric mucosal microcirculatory alterations in the rat. Microcirc Endothelium Lymphatics 1991;7:133-158.
16. Andrews FJ, Malcontenti C, O'Brien PE: Sequence of gastric mucosal injury following ischemia and reperfusion. Dig Dis Sci 1992;37:1356-1361.
17. Zimmerman BJ, Granger DN: Oxygen free radicals and the gastrointestinal tract: Role in ischemia-reperfusion injury. Hepatogastroenterology 1994;41:337-342.
18. Rodriguez-Reynoso S, Leal C, Portilla E, Olivares N, Muniz J: Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: Possible role of tumor necrosis factor-alpha and nitric oxide. J Surg Res 2001;100:141-149.
19. Cuzzocrea S, Costantino G, Gitto E, Mazzon E, Fulia F, Serraino I, Cordaro S, Barberi I, De Sarro A, Caputi AP: Protective effects of melatonin in ischemic brain injury. J Pineal Res 2000;29:217-227.
20. Pozo D, Reiter RJ, Calvo JR, Guerrero JM: Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997;65:430-442.
21. Pei Z, Ho HT, Cheung RT: Pre-treatment with melatonin reduces volume of cerebral infarction in a permanent middle cerebral artery occlusion stroke model in the rat. Neurosci Lett 2002;318:141-144.
22. Simonini G, Pignone A, Generini S, Falcini F, Cerinic MM, Gabriele S, Alberto P, Sergio G, Fernanda F, Marco MC: Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology 2000;155:1-15.
23. Brzozowski T, Konturek PC, Konturek SJ, Pajdo R, Bielanski W, Brzozowska I, Stachura J, Hahn EG: The role of melatonin and L-tryptophan in prevention of acute gastric lesions induced by stress, ethanol, ischemia, and aspirin. J Pineal Res 1997;23:79-89.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizating the principle of protein-dye binding. Anal Biochem 1976;72:248-274.
25. Knowles RG, Palacios M, Palmer RM, Moncada S: Kinetic characteristics of nitric oxide synthase from rat brain. Biochem J 1990;269:207-210.
26. Alarcón de la Lastra C, Nieto A, Martin MJ, Cabre F, Herrerias JM, Motilva V: Gastric toxicity of racemic ketoprofen and its enantiomers in rat: Oxygen radical generation and COX-expression. Inflamm Res 2002;51:51-57.
27. Motilva V, Cabeza J, Alarcon de la Lastra C: New issues about melatonin and its effects on the digestive system. Curr Pharm Des 2001;7:909-931.
28. Kato K, Murai I, Asai S, Matsuno Y, Komuro S, Kaneda N, Iwasaki A, Ishikawa K, Nakagawa S, Arakawa Y, Kuwayama H: Protective role of melatonin and the pineal gland in modulating water immersion restraint stress ulcer in rats. J Clin Gastroenterol 1998;27:S110-S115.
29. Peskar BM, Maricic N: Role of prostaglandins in gastroprotection. Dig Dis Sci 1998;43:23-29.
30. Cryer B: Mucosal defense and repair: Role of prostaglandins in the stomach and duodenum. Gastroenterol Clin North Am 2001;30:877-894.
31. Motilva V, Lopez A, Martin MJ, La Casa C, Alarcon de la Lastra C: Cytoprotective activity of cisapride on experimental gastric mucosal lesions induced by ethanol. Role of endogenous prostaglandins. Prostaglandins 1996;52:63-74.
32. Bubenik GA, Ayles HL, Friendship RM, Brown GM, Ball RO: Relationship between melatonin levels in plasma and gastrointestinal tissues and the incidence and severity of gastric ulcers in pigs. J Pineal Res 1998;24:62-66.
33. Sjoblom M, Flemstrom G. Central nervous stimuli increase duodenal bicarbonate secretion by release of mucosal melatonin. J Physiol Pharmacol 2001;52:671-678.
34. Vane JR, Botting RM: New insights into the model of action of anti-inflammatory drugs. Inflamm Res 1995;44:1-10.
35. Masferrer JL, Isakson PC, Seibert K: Cyclooxygenase-2 inhibitors: A new class of anti-inflammatory agents that spare the gastrointestinal tract. Gastroenterol Clin North Am 1996;25:363-372.
36. Gretzer B, Ehrlich K, Maricic N, Lambrecht N, Respondek M, Peskar BM: Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach. Br J Pharmacol 1998;123:927-935.
37. Chan FK: Helicobacter pylori and nonsteroidal anti-inflammatory drugs. Gastroenterol Clin North Am 2001;30:937-952.
38. Schmassmann A: Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs. Am J Med 1998;104:43S-51S.
39. Sánchez S, Martín MJ, Ortiz P, Motilva V, Herrerías JM, Alarcón de la Lastra C: Role of prostaglandins and nitric oxide in gastric damage induced by metamizol in rats. Inflamm Res 2002;51:385-392.
40. Tanaka A, Araki H, Hase S, Komoike Y, Takeuchi K: Up-regulation of COX-2 by inhibition of COX-1 in the rat: A key to NSAID-induced gastric injury. Aliment Pharmacol Ther 2002;16:90-101.
41. Kishimoto Y, Wada K, Nakamoto K, Kawasaki H, Hasegawa J: Levels of cyclooxygenase-1 and -2 mRNA expression at various stages of acute gastric injury induced by ischemia-reperfusion in rat. Arch Biochem Biophys 1998;352:153-157.
42. Brzozowski, T, Konturek PC, Konturek SJ, Sliwowski Z, Drozdowicz D, Stachura J, Pajdo R, Hahn EG: Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion- induced gastric lesions. Eur J Pharmacol 1999;385:47-61.
43. Kato K, Murai I, Asai S, Takahashi Y, Nagata T, Komuro S, Mizuno S, Iwasaki A, Ishikawa K, Arakawa Y: Circadian rhythm of melatonin and prostaglandin in modulation of stress-induced gastric mucosal lesions in rats. Aliment Pharmacol Ther 2002;16:29-34.
44. Cuzzocrea S, Costantino G, Mazzon E, Caputi AP: Regulation of prostaglandin production in carrageenan-induced pleurisy by melatonin. J Pineal Res 1999;27:9-14.
45. Cuzzocrea S, Mazzon E, Serraino I, Lepore V, Terranova ML, Ciccolo A, Caputi AP: Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 2001;30:1-12.
46. Bertolini A, Ottani A, Sandrini M: Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res 2001;44:437-450.
47. Lamas S, Perez-Sala D, Moncada S: Nitric oxide: From discovery to the clinic. Trends Pharmacol Sci 1998;19:436-438.
48. Szabo C: The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996;6:79-88.
49. Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabó S: Melatonin is a scavenger of peroxynitrite. Life Sci 1997;60:169-174.
50. Guerrero JM, Reiter RJ, Ortiz GG, Pablos MI, Sewerynek E, Chuang J: Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones unguiculatus). J Pineal Res 1997;23:24-31.
51. Calatayud S, Sanz MJ, Canet A, Bello R, de Rojas FD, Esplugues JV: Mechanisms of gastroprotection by transdermal nitroglycerin in the rat. Br J Pharmacol 1999;127:1111-1118.
52. Wallace JL: Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Mechanisms of protection and healing: Current knowledge and future research. Am J Med 2001;110:19S-23S.
53. Jiménez D, Martín MJ, Pozo D, Alarcón C, Esteban J, Bruseghini L, Esteras A, Motilva V: Mechanisms involved in protection afforded by L-arginine in ibuprofen-induced gastric damage: Role of nitric oxide and prostaglandins. Dig Dis Sci 2002;47:44-53.
54. Hobbs AJ: Soluble guanylate cyclase: The forgotten sibling. Trends Pharmacol Sci 1997;18:484-491.
55. Ignarro LJ, Cirino G, Casini A, Napoli C: Nitric oxide as a signalling molecule in the vascular system: An overview. J Cardiovasc Pharmacol 1999;34:879-886.
56. Mayer B, Pfeiffer S, Schrammel A, Koesling D, Schmidt K, Brunner A. New pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J Biol Chem 1998;273:3264-3270.